Share Fund
An open-end focused equity fund that seeks to achieve capital appreciation through investing predominantly in Indian companies/sectors with high growth rates or potential.
Suitability
This product is suitable for investors who are seeking
• This product is suitable for Investors who are seeking
• Long term capital appreciation.
• A fund that invests in stocks of companies / sectors with high growth rates or above average potential.
| Scheme Class | Equity |
| Scheme Category | Focused Fund |
| Expense Ratio | 0.81% |
| Min subscription | ₹ 5,000 |
| Scheme Type | Open-ended |
| Scheme AUM (in Crs.) | ₹ 9,359 |
| AMC AUM (in Crs.) | ₹ 1,18,912 |
| Min Addition Subscription | ₹ 1,000 |
| Benchmark Type | S&P BSE 500 India TR INR |
| Exit Load | Exit load of 1.0%, if redeemed between (0-1) years. No Exit load, if redeemed after 1 years. |
| Fund | Min SIP Inv. | Min Inv. | Returns 3Y |
|---|---|---|---|
Bandhan Focused Equity Fund - Direct Plan | 1000 | 1000 | 16.61% |
Axis Focused 25 Fund - Direct Plan | 100 | 100 | 13.65% |
Motilal Oswal Focused Fund - Direct Plan | 1000 | 1000 | 17.49% |
| Company | Holding Type | Asset(%) |
|---|---|---|
ICICI Bank Ltd | Equity | 9 |
HDFC Bank Ltd | Equity | 9 |
Larsen & Toubro Ltd | Equity | 6 |
Axis Bank Ltd | Equity | 5 |
Infosys Ltd | Equity | 5 |
Cipla Ltd Shs Dematerialised | Equity | 5 |
Call, Cash & Other Assets | Cash - Collateral | 5 |
Bharti Airtel Ltd | Equity | 4 |
KEI Industries Ltd | Equity | 4 |
Sun Pharmaceuticals Industries Ltd | Equity | 4 |
| Asset | Percent |
|---|---|
Equity | 95 |
Cash - Collateral | 5 |
| Sector | Percent |
|---|---|
Financial Services | 32 |
Industrials | 19 |
Consumer Cyclical | 10 |
Healthcare | 9 |
Technology | 6 |
Fund Manager
Ajay Argal
1+ years of experience
Varun Sharma
0+ years of experience
Sandeep Manam
1+ years of experience
About
Phone
1800 425 4255
Address
Indiabulls Finance Centre; Tower 2, 12th and 13th Floor,Senapati Bapat Marg; Elphinstone Road (W) Mumbai 400013, - 400013
